Tateishi, Keisuke

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma

Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Bierie, B., Tada, M., Mohri, D., Miyabayashi, K., Asaoka, Y., Maeda, S., et al. (2011) · Journal of Clinical Investigation

Pancreatic and Hepatic Oncology ResearchChemokine receptors and signaling

Cited by 256

Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis

Kurosaki, S., Nakagawa, H., Hayata, Y., Kawamura, S., Matsushita, Y., Yamada, T., Uchino, K., Hayakawa, Y., Suzuki, N., Hata, M., et al. (2021) · JHEP Reports

Liver physiology and pathologyWnt/β-catenin signaling in development and cancer

Cited by 34

Targeting autophagy as a therapeutic strategy against pancreatic cancer

Yamamoto, K., Iwadate, D., Kato, H., Nakai, Y., Tateishi, K., & Fujishiro, M. (2022) · Journal of Gastroenterology

Autophagy in Disease and TherapyPancreatic and Hepatic Oncology Research

Cited by 29

Post‐operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A , p53, and SMAD4 expression

Masugi, Y., Takamatsu, M., Tanaka, M., Hara, K., Inoue, Y., Hamada, T., Suzuki, T., Arita, J., Hirose, Y., Kawaguchi, Y., et al. (2023) · The Journal of Pathology: Clinical Research

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 23